Prostate Cancer

AFT-19 trial: Investigating androgen blockade intensification in prostate cancer.

Cell-active inhibitor designed for methyltransferase KMT9.

Temporal evolution reveals dual lineages in prostate cancer transformation.

Study analyzes the cost-effectiveness of focal therapy, radical prostatectomy, and radiotherapy for prostate cancer.

Enzalutamide improves recurrent prostate cancer prognosis.

Using Salmonella to fight pancreatic cancer: How CD8 T cells can help.

Using germline sequencing to guide prostate cancer gene panel testing.

Eating early and often may reduce your risk of Type 2 Diabetes.

Potential treatment approach for over 90% of prostate cancers.

There is a link between central adiposity and risk of death from prostate cancer.

Prostate cancer is the most common cancer in men in the UK*, yet we still don't know all of its causes.

Other than skin cancer, prostate cancer is the most common cancer in men in the western world. About 1 man in 9 will be diagnosed...